Lanean...
Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
Objective: Perampanel is an approved anti-seizure drug. A new formulation of perampanel fine granules (FG; 1% perampanel) has been developed for patients who are unable to take tablets. Bioequivalence between the 4-mg FG and tablet perampanel formulations, as well as their safety and tolerability, w...
Gorde:
| Argitaratua izan da: | Int J Clin Pharmacol Ther |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dustri-Verlag Dr. Karl Feistle
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7659282/ https://ncbi.nlm.nih.gov/pubmed/32870153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CP203781 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|